A detailed history of Journey Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Journey Advisory Group, LLC holds 29,440 shares of LLY stock, worth $23.7 Million. This represents 2.83% of its overall portfolio holdings.

Number of Shares
29,440
Previous 28,818 2.16%
Holding current value
$23.7 Million
Previous $16.8 Million 36.34%
% of portfolio
2.83%
Previous 2.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $368,348 - $492,798
622 Added 2.16%
29,440 $22.9 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $152,305 - $179,547
-290 Reduced 1.0%
28,818 $16.8 Million
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $216,915 - $299,050
-499 Reduced 1.69%
29,108 $15.6 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $252,182 - $337,196
-719 Reduced 2.37%
29,607 $13.9 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $453,830 - $533,002
1,461 Added 5.06%
30,326 $10.4 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $1.25 Million - $1.46 Million
3,900 Added 15.62%
28,865 $10.6 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $667,376 - $760,545
2,251 Added 9.91%
24,965 $8.07 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $1.25 Million - $1.47 Million
4,497 Added 24.69%
22,714 $7.36 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $437,931 - $544,237
1,866 Added 11.41%
18,217 $5.22 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $112,200 - $139,240
499 Added 3.15%
16,351 $4.52 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $84,208 - $103,629
-380 Reduced 2.34%
15,852 $3.66 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $73,122 - $94,583
405 Added 2.56%
16,232 $3.73 Million
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $67,206 - $87,002
409 Added 2.65%
15,827 $2.96 Million
Q4 2020

Jan 19, 2021

BUY
$130.46 - $172.63 $2.01 Million - $2.66 Million
15,418 New
15,418 $2.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.